GlassScript(Br4) Coronary Undivided
Payments companies reported to CMS as associated with (Br4) Coronary Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Br4) Coronary Undivided, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Br4) Coronary Undivided
These are the largest totals companies reported as associated with (Br4) Coronary Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Philipp Wiesner | Springfield, MO | Interventional Cardiology | $530.80 |
| Uzochukwu Ibe | Akron, OH | Interventional Cardiology | $408.69 |
| Meghan Patni | Lees Summit, MO | Interventional Cardiology | $237.46 |
| Prince Sethi | Springfield, MO | Interventional Cardiology | $237.44 |
| Amir Lotfi | Springfield, MA | Interventional Cardiology | $222.45 |
| Htin Aung | Fairhope, AL | Interventional Cardiology | $220.24 |
| Amod Amritphale | Springfield, MO | Interventional Cardiology | $213.49 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $191.32 |
| Julius Elmore | Macon, GA | Cardiovascular Disease | $169.76 |
| Jessica Birchem | Springfield, MO | Interventional Cardiology | $157.85 |
Prescribed (Br4) Coronary Undivided?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.